UCB - 应收帐款人





应收帐款人 更改 日
Alcon AG USD 2.01B 525M 2026-03
Almirall EUR 175.93M 17.87M 2025-12
Amarin USD 126.83M 477K 2025-12
argenx SE USD 1.66B 458.83M 2025-12
AstraZeneca USD 17.88B 1.17B 2026-03
Bayer EUR 18.55B 4.36B 2026-03
Genmab DKK 1.17B 119M 2025-12
GlaxoSmithKline GBP 7.94B 178M 2026-03
GRIFOLS EUR 958M 106M 2026-03
Hikma Pharmaceutical USD 1.08B 27M 2025-12
Lakefront Biotherapeutics EUR 54.03M 145.72M 2026-03
Lonza CHF 1.78B 55M 2025-12
Merck EUR 4.81B 373M 2026-03
Novartis USD 9.6B 2.69B 2026-03
Orion EUR 699.6M 270.4M 2026-03
Recordati EUR 764.73M 88.12M 2026-03
Roche Holding CHF 11.9B 460M 2025-12
Sanofi EUR 482M 85M 2026-03
UCB EUR 1.97B 54M 2025-12
Unibail Rodamco EUR 1.18B 244.4M 2025-12